K. Noonan

1.5k total citations
35 papers, 1.2k citations indexed

About

K. Noonan is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, K. Noonan has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in K. Noonan's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Maternal Mental Health During Pregnancy and Postpartum (7 papers) and Regulation of Appetite and Obesity (5 papers). K. Noonan is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Maternal Mental Health During Pregnancy and Postpartum (7 papers) and Regulation of Appetite and Obesity (5 papers). K. Noonan collaborates with scholars based in United Kingdom, United States and Germany. K. Noonan's co-authors include Jolanta U. Weaver, Peter Kopelman, John P. Monson, W. Garry John, John T. Cunningham, Alison Edwards, Kathy Evans, Sharon K. Hunter, M. Camille Hoffman and Robert Freedman and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Diabetologia.

In The Last Decade

K. Noonan

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Noonan United Kingdom 19 647 276 228 167 162 35 1.2k
James T. Lane United States 18 418 0.6× 263 1.0× 99 0.4× 63 0.4× 145 0.9× 34 1.1k
Christian Denzer Germany 19 548 0.8× 220 0.8× 162 0.7× 92 0.6× 125 0.8× 54 1.3k
I. F. Casson United Kingdom 14 589 0.9× 120 0.4× 232 1.0× 267 1.6× 158 1.0× 35 1.4k
Giuseppina Rosaria Umano Italy 21 408 0.6× 207 0.8× 108 0.5× 125 0.7× 181 1.1× 79 1.2k
C Bloch United States 13 565 0.9× 143 0.5× 173 0.8× 65 0.4× 209 1.3× 29 1.3k
Gesthimani Mintziori Greece 20 502 0.8× 163 0.6× 156 0.7× 113 0.7× 209 1.3× 58 1.5k
Arnold H. Slyper United States 18 358 0.6× 279 1.0× 138 0.6× 142 0.9× 401 2.5× 42 1.3k
S C Hunt United States 17 165 0.3× 385 1.4× 147 0.6× 325 1.9× 209 1.3× 27 1.1k
Károly Cseh Hungary 18 143 0.2× 377 1.4× 127 0.6× 125 0.7× 172 1.1× 53 1.3k
David Curb United States 17 330 0.5× 213 0.8× 144 0.6× 336 2.0× 326 2.0× 26 1.4k

Countries citing papers authored by K. Noonan

Since Specialization
Citations

This map shows the geographic impact of K. Noonan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Noonan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Noonan more than expected).

Fields of papers citing papers by K. Noonan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Noonan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Noonan. The network helps show where K. Noonan may publish in the future.

Co-authorship network of co-authors of K. Noonan

This figure shows the co-authorship network connecting the top 25 collaborators of K. Noonan. A scholar is included among the top collaborators of K. Noonan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Noonan. K. Noonan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Denise, K. Noonan, Robert L. Page, et al.. (2024). A DESCRIPTION OF PROCESSES EMPLOYED AND CHALLENGES ENCOUNTERED TO OBTAIN PATIENT OUT-OF-POCKET COSTS FOR THE POCKET-COST-HF TRIAL. Journal of the American College of Cardiology. 83(13). 285–285. 1 indexed citations
2.
Dickert, Neal W., J. Kelly Davis, Scott D. Halpern, et al.. (2024). Integrating Out-of-Pocket Costs Into Shared Decision-Making for Heart Failure With Reduced Ejection Fraction: A Stepped-Wedge Trial (POCKET-COST-HF). Circulation Cardiovascular Quality and Outcomes. 18(1). e011273–e011273. 2 indexed citations
3.
Freedman, Robert, Sharon K. Hunter, Amanda J. Law, et al.. (2020). Maternal choline and respiratory coronavirus effects on fetal brain development. Journal of Psychiatric Research. 128. 1–4. 23 indexed citations
4.
Freedman, Robert, Sharon K. Hunter, K. Noonan, et al.. (2020). Maternal Prenatal Depression in Pregnancies With Female and Male Fetuses and Developmental Associations With C-reactive Protein and Cortisol. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 6(3). 310–320. 16 indexed citations
5.
Hoffman, M. Camille, et al.. (2019). Interaction of maternal choline levels and prenatal Marijuana's effects on the offspring. Psychological Medicine. 50(10). 1716–1726. 19 indexed citations
6.
Hunter, Sharon K., M. Camille Hoffman, Angelo D’Alessandro, et al.. (2019). Male fetus susceptibility to maternal inflammation: C-reactive protein and brain development. Psychological Medicine. 51(3). 450–459. 41 indexed citations
7.
Freedman, Robert, Sharon K. Hunter, Amanda J. Law, et al.. (2019). Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development. The Journal of Pediatrics. 208. 198–206.e2. 38 indexed citations
8.
Pati, Susmita, et al.. (2012). Reading Level of Medicaid Renewal Applications. Academic Pediatrics. 12(4). 297–301. 22 indexed citations
10.
Noonan, K., et al.. (1997). Assessment of the performance of a capture immunoassay for the bone isoform of alkaline phosphatase in serum. Clinica Chimica Acta. 263(2). 165–175. 11 indexed citations
11.
Armstrong, April W., et al.. (1997). Reduced calcium dialysate in CAPD patients: efficacy and limitations. Nephrology Dialysis Transplantation. 12(6). 1223–1228. 19 indexed citations
12.
Noonan, K., et al.. (1992). 06 mM Calcium dialysate in CAPD Effective strategy for treating persistent hypercalcaemia in patients receiving calcium carbonate. Nephrology Dialysis Transplantation. 7(7). 753–754. 1 indexed citations
13.
Bearcroft, C P, et al.. (1991). Thyroxine replacement in post‐radioiodine hypothyroidism. Clinical Endocrinology. 34(2). 115–118. 11 indexed citations
14.
Weaver, Jolanta U., Jeffrey M P Holly, Peter Kopelman, et al.. (1990). DECREASED SEX HORMONE BINDING GLOBULIN (SHBG) AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP‐1) IN EXTREME OBESITY. Clinical Endocrinology. 33(3). 415–422. 67 indexed citations
15.
Weaver, Jolanta U., et al.. (1990). IMPAIRED PROLACTIN SECRETION AND BODY FAT DISTRIBUTION IN OBESITY. Clinical Endocrinology. 32(5). 641–646. 12 indexed citations
16.
McCarthy, Mark I., K. Noonan, J. A. H. Wass, & John P. Monson. (1990). FAMILIAL ACROMEGALY: STUDIES IN THREE FAMILIES. Clinical Endocrinology. 32(6). 719–728. 27 indexed citations
17.
Noonan, K., et al.. (1989). Long-Term Effect of Low Calcium Dialysate on Parathyroid Activity in Dialysis Patients Treated with Calcium Carbonate as a Phosphate Binder. Nephrology Dialysis Transplantation. 4(8). 759–759. 12 indexed citations
18.
Kopelman, Peter, et al.. (1988). GROWTH HORMONE RESPONSE TO GROWTH HORMONE RELEASING FACTOR IN DIABETIC MEN. Clinical Endocrinology. 28(1). 33–38. 23 indexed citations
19.
Kopelman, Peter & K. Noonan. (1986). GROWTH HORMONE RESPONSE TO LOW DOSE INTRAVENOUS INJECTIONS OF GROWTH HORMONE RELEASING FACTOR IN OBESE AND NORMAL WEIGHT WOMEN. Clinical Endocrinology. 24(2). 157–164. 38 indexed citations
20.
Kopelman, Peter & K. Noonan. (1985). Impaired Growth Hormone Secretion in Obesity. Clinical Science. 69(s12). 42P–42P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026